Theseus Pharmaceuticals Statistics
Total Valuation
Covivio has a market cap or net worth of EUR 6.21 billion. The enterprise value is 19.68 billion.
Market Cap | 6.21B |
Enterprise Value | 19.68B |
Important Dates
The last earnings date was Monday, July 21, 2025.
Earnings Date | Jul 21, 2025 |
Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Covivio has 110.79 million shares outstanding. The number of shares has increased by 9.74% in one year.
Current Share Class | 110.79M |
Shares Outstanding | 110.79M |
Shares Change (YoY) | +9.74% |
Shares Change (QoQ) | -1.17% |
Owned by Insiders (%) | 0.27% |
Owned by Institutions (%) | 34.92% |
Float | 61.50M |
Valuation Ratios
The trailing PE ratio is 14.96 and the forward PE ratio is 12.11. Covivio's PEG ratio is 5.23.
Price/FFO Ratio | n/a |
Price/AFFO Ratio | n/a |
PE Ratio | 14.96 |
Forward PE | 12.11 |
PS Ratio | 5.44 |
PB Ratio | 0.52 |
P/TBV Ratio | 0.79 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 5.23 |
Enterprise Valuation
EV / Earnings | 47.10 |
EV / Sales | 17.24 |
EV / EBITDA | 18.32 |
EV / EBIT | 20.80 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.92 |
Debt / EBITDA | 10.27 |
Debt / FCF | n/a |
Interest Coverage | 2.28 |
Financial Efficiency
Return on equity (ROE) is 5.36% and return on invested capital (ROIC) is 2.54%.
Return on Equity (ROE) | 5.36% |
Return on Assets (ROA) | 2.31% |
Return on Invested Capital (ROIC) | 2.54% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 1.15M |
Profits Per Employee | 422,548 |
Employee Count | 989 |
Asset Turnover | 0.04 |
Inventory Turnover | 0.23 |
Taxes
In the past 12 months, Covivio has paid 89.50 million in taxes.
Income Tax | 89.50M |
Effective Tax Rate | 12.27% |
Stock Price Statistics
The stock price has increased by +17.41% in the last 52 weeks. The beta is 1.37, so Covivio's price volatility has been higher than the market average.
Beta (5Y) | 1.37 |
52-Week Price Change | +17.41% |
50-Day Moving Average | 52.59 |
200-Day Moving Average | 51.04 |
Relative Strength Index (RSI) | 67.42 |
Average Volume (20 Days) | 108,561 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Covivio had revenue of EUR 1.14 billion and earned 417.90 million in profits. Earnings per share was 3.75.
Revenue | 1.14B |
Gross Profit | 1.08B |
Operating Income | 946.20M |
Pretax Income | 729.50M |
Net Income | 417.90M |
EBITDA | 1.07B |
EBIT | 946.20M |
Earnings Per Share (EPS) | 3.75 |
Balance Sheet
The company has 1.36 billion in cash and 11.04 billion in debt, giving a net cash position of -9.67 billion or -87.32 per share.
Cash & Cash Equivalents | 1.36B |
Total Debt | 11.04B |
Net Cash | -9.67B |
Net Cash Per Share | -87.32 |
Equity (Book Value) | 12.02B |
Book Value Per Share | 74.22 |
Working Capital | 1.93B |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 94.43%, with operating and profit margins of 82.85% and 36.59%.
Gross Margin | 94.43% |
Operating Margin | 82.85% |
Pretax Margin | 63.88% |
Profit Margin | 36.59% |
EBITDA Margin | 94.09% |
EBIT Margin | 82.85% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 6.15%.
Dividend Per Share | 3.50 |
Dividend Yield | 6.15% |
Dividend Growth (YoY) | 6.06% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.74% |
Shareholder Yield | -3.59% |
Earnings Yield | 6.73% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on January 5, 2004. It was a forward split with a ratio of 5.
Last Split Date | Jan 5, 2004 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |